^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    miR‑625‑3p overexpression

    i
    Other names: MiR625, MicroRNA 625, Hsa-MiR-625-3p, Hsa-MiR-625-5p, MIMAT0004808, MIMAT0003294, Hsa-MiR-625, MI0003639, MiRN625, RF00027, MiR625
    Entrez ID:
    693210
    Related biomarkers:
    Expression
    almost3years
    MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma. (PubMed, J Ovarian Res)
    miR-625-3p promotes HGSOC growth, involves chemotherapy resistance and might serve as a potential biomarker to predict chemotherapy response and prognosis in HGSOC.
    Journal • IO biomarker
    |
    PTEN (Phosphatase and tensin homolog) • BCL2 (B-cell CLL/lymphoma 2) • BAX (BCL2-associated X protein) • MIR625 (MicroRNA 625)
    |
    BCL2 expression • PTEN expression • miR‑625‑3p overexpression
    |
    cisplatin
    over4years
    MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression. (PubMed, Eur Rev Med Pharmacol Sci)
    MicroRNA-625-3p is highly expressed in OSCC, which promotes cell migration of OSCC by regulating SCAI expression.
    Journal
    |
    CDH1 (Cadherin 1) • MIR625 (MicroRNA 625)
    |
    CDH1 expression • miR‑625‑3p overexpression